For nearly four decades, vaccine manufacturers have operated with near-total legal immunity, shielded from accountability when their products injure or kill. The National Childhood Vaccine Injury Act (NCVIA) of 1986—sold as a way to ensure vaccine availability—has instead become a corporate protection racket, denying justice to thousands of families while allowing pharmaceutical giants to profit without consequence. Now, a bold new bill, H.R. 4668—the End the Vaccine Carveout Act—introduced by Rep. Paul Gosar, seeks to dismantle this corrupt system, restoring the right of injured individuals to sue vaccine manufacturers directly. If passed, this legislation could finally force the industry to answer for its failures, remove dangerous products from the market, and compensate those who have suffered in silence for far too long.
Key points:
- The 1986 NCVIA granted vaccine manufacturers blanket immunity from lawsuits, funneling injury claims into a flawed federal compensation program (VICP) that rejects nearly half of all cases.
- The VICP operates as a “kangaroo court,” with strict criteria that prevent most families from receiving justice, while manufacturers face zero financial or legal consequences.
- COVID-19 vaccines were further shielded under the PREP Act, preventing victims from suing—but H.R. 4668 would remove this protection.
- The bill eliminates the statute of limitations for filing claims, allowing retroactive cases and giving families long denied justice a chance at restitution.
- Vaccine manufacturers have avoided rigorous safety testing, relying on short-term studies and non-inert placebos, while enjoying guaranteed profits from government-mandated schedules.
The 1986 betrayal: How Congress sold out families to protect Big Pharma
The origins of the NCVIA trace back to the early 1980s, when lawsuits against vaccine manufacturers—particularly over the DTP (diphtheria-tetanus-pertussis) vaccine—began piling up. Parents of children left with seizures, brain damage, and even death were winning multi-million-dollar settlements, threatening the financial stability of pharmaceutical companies. Instead of demanding safer vaccines, Congress caved to industry pressure, passing a law that stripped families of their right to sue.
Under the NCVIA, all injury claims were redirected to the VICP—a system critics call a “kangaroo court” where the deck is stacked against victims. The burden of proof is impossibly high, the definitions of “vaccine injury” are arbitrarily narrow, and the process drags on for years. Even when families win, compensation is often a pittance compared to the lifelong medical costs of caring for an injured child. Meanwhile, manufacturers continue raking in billions, shielded from any real accountability.
A rigged system: How the VICP denies justice
The VICP is not a court—it’s a bureaucratic maze designed to protect the industry. Unlike civil lawsuits, where discovery processes and jury trials expose corporate misconduct, the VICP operates behind closed doors. Cases are decided by a “Special Master,” not a judge, and plaintiffs are barred from presenting key evidence. Worse, the program is funded by a 75-cent excise tax on each vaccine dose—meaning the public, not the manufacturers, foots the bill for injuries.
Consider the case of Hannah Poling, a child who developed autism and encephalopathy after receiving nine vaccines in a single day. Though the government conceded her injuries were vaccine-related, her family spent years fighting for compensation. Thousands of others aren’t so lucky—their claims dismissed outright because their child’s condition isn’t on the VICP’s narrowly defined “injury table.”
COVID-19 vaccines: The ultimate liability scam
The PREP Act, passed in 2005, expanded Big Pharma’s liability shield to include “countermeasures” during public health emergencies—like COVID-19 vaccines. This meant that even as reports of heart inflammation, blood clots, and neurological damage surged, victims had no legal recourse. H.R. 4668 would strip COVID-19 vaccines of this special protection, allowing injured individuals to sue manufacturers directly.
Pfizer, Moderna, and Johnson & Johnson have made billions while dodging accountability. Internal documents reveal they knew about risks—like myocarditis in young males—yet downplayed them. Under the current system, they face zero consequences. But if H.R. 4668 passes, the floodgates could open, forcing these companies to answer for their negligence in real courts, before real juries.
You must be logged in to post a comment.